Earth Science Tech, Inc. (ETST) Inks Deal to Develop its MSN-2 Medical Device
Deal includes design, development and clinical testing of MSN-2 medical device-related services Study-specific testing will center on sexually-transmitted infections (“STIs”) World Health Organization estimates that 357 million new STIs are contracted yearly Global diagnostic market for STIs projected at more than $200 billion by 2022 Earth Science Tech, Inc. (OTC: ETST), an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development, has signed a deal with a private laboratory for clinical studies related to its MSN-2 medical device. The partnership, announced in a January 9 news release (http://cnw.fm/9pAPP), brings together…

















